The Fallacy of the CE Mark (Revised Content)

Due to a Notice of Concern issued under s14(2) of the Defamation Act 2005 (NSW) by Oncosil Limited (ASX : OSL), this content has been re-posted without any reference to OSL. Thanks to readers who gave me feedback that the content was useful and should be re-posted in a redacted form. Everyone loves the CE (Conformité…

Happy New Year – 2016

It’s been an interesting year. When I started this site I really didn’t know what was going to happen… in most respects, it has exceeded my expectations. A Few Opening Remarks On a positive note, I genuinely felt support for the mission of trying to create a fresh dialogue around the quality and transparency of ASX-listed companies operating in this…

IRESSt My Case

Some of you correctly read between the lines of David Langsam’s (Biotech Daily) perfunctory reporting last week, and ascertained that I was pissed off at him. I was, though in truth I probably shouldn’t have been. The problem is that David uses CommSecIRESS financial markets software for his share market reporting activities because he thinks that…

A Little Rest

Hi there… it’s been a while. I hope you are doing fine? You’re looking great, by the way… I took a break. Between a pile of business travel over the past few weeks*, several new ventures getting off the ground and the pending arrival of my second child, I have just been swamped. But I…

The Shock Jock : Market Roundup

You give me a royal pain in the ass, if you want to know the truth. – Holden (J.D. Salinger) When I announced earlier in the week that I would no longer be commenting on HotCopper, I thought that would be the end of the annoying, low-intelligence comments mostly aimed at some degree of personal…

A bumpy road for TIS

Tissue Therapies (ASX: TIS) has had a bit of a rough time the last month or so. They mostly have my sympathies. This is a company that, on the whole, appears to have to have done some things in a fairly grown up fashion and, quite frankly, it should be thoroughly unsurprising to experience some regulatory…